Company Overview
Corteva, Inc. operates within the agricultural sector, functioning as a primary supplier of agricultural inputs through its core segments of Seed and Crop Protection. The Seed segment is dedicated to developing and supplying advanced germplasm and traits designed to produce optimum yield for farms, while offering technologies that enhance resistance to weather, disease, and insects. This entity operates within the Basic Materials sector and the Agricultural Inputs industry, positioning it as a critical provider of essential biological and chemical solutions for global food production. The company demonstrates significant scale with a market capitalization of $55.14B and an annual revenue of $17.40B, supported by an employee base of 21500 individuals. These valuation and revenue figures indicate that Corteva maintains a substantial market presence, reflecting its established role in a capital-intensive industry where consistent cash generation is vital for sustaining operations and funding research into trait technologies.
Financial Health
The company reported a trailing twelve-month revenue of $17.40B, generating a net income of $1.19B and an EBITDA of $3.80B during the same period. The substantial gap between the $17.40B revenue and the $1.19B net income reveals a cost structure where operating expenses, including cost of goods sold, research and development, and selling costs, absorb approximately 93.7% of total sales before arriving at the bottom line. Free cash flow stands at $2.93B, which provides the company with considerable financial flexibility to fund capital expenditures, pursue acquisitions, or manage liquidity needs without relying heavily on external financing. The gross margin is reported at 47.3%, indicating that the company retains a significant portion of sales revenue after direct production costs, while the operating margin of 5.6% and profit margin of 6.3% suggest that overhead and administrative expenses consume a large fraction of the gross profit. On the balance sheet, the company holds $4.53B in cash against $3.00B in debt, resulting in a debt-to-equity ratio of 12.28, which indicates a highly leveraged position relative to equity but suggests adequate liquidity given the cash reserves. The current ratio is 1.43, indicating that the company possesses 1.43 dollars of current assets for every dollar of current liabilities, which points to a conservative stance regarding short-term liquidity obligations. Return on equity is 5.0% and return on assets is 3.9%, metrics that reveal how management effectiveness translates into shareholder value and asset utilization, though these returns are moderate relative to the high multiple valuations seen in the sector.
Valuation Assessment
Corteva, Inc. currently trades with a trailing P/E ratio of 46.85 and a forward P/E of 20.26, a significant disparity that implies the market expects earnings to grow substantially to meet the lower forward multiple in the coming years. The price-to-book ratio is 2.28, indicating that the market values the company at more than double its book value, which suggests a premium placed on its intangible assets, brand equity, and growth potential beyond tangible capital. Alternative valuation metrics further illustrate this positioning, with a price-to-sales ratio of 3.17 and an EV/EBITDA of 14.17, suggesting that investors are willing to pay a premium for revenue and earnings power relative to the broader market averages. The stock has a 52-week high of $82.81 and a 52-week low of $53.40, meaning the current price sits somewhere within this established trading range, reflecting recent market volatility and investor sentiment adjustments. With a beta of 0.72, the stock exhibits lower price volatility relative to the broader market, moving less than 72% as much as the general market index, which offers a degree of stability for portfolios seeking lower correlation with equity market swings.
Growth & Income
Revenue growth year-over-year stands at -1.7%, while earnings growth year-over-year is marked as N/A, indicating that the company is currently navigating a contraction in top-line sales without available comparative earnings expansion data. Since earnings growth is not explicitly quantified in the provided data, the implication is that the decline in revenue is the primary driver of financial performance changes rather than a divergence between revenue and earnings trajectories. As a dividend payer, the company offers a dividend yield of 0.9% with a payout ratio of 40.0%, a level that appears sustainable given the free cash flow generation and the fact that the payout consumes less than half of the available earnings. This income profile suggests that while the company is not in a high-growth acceleration phase indicated by positive revenue expansion, it maintains a disciplined approach to capital allocation by returning a steady stream of cash to shareholders. The overall growth and income profile reflects a mature business unit focused on steady cash generation through established seed and crop protection technologies rather than rapid expansion, balancing the recent revenue headwinds with consistent dividend commitments.